E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/6/2006 in the Prospect News Biotech Daily.

Bionutrics changing name to Synovics Pharmaceuticals

By Ted A. Knutson

Washington, March 6 - Bionutrics, Inc. said Monday it is changing its name to Synovics Pharmaceuticals, Inc.

Synovics is a Phoenix-based specialty pharmaceutical company with proprietary drug formulation and delivery technologies used in the development of an extensive pipeline of difficult-to-formulate, oral controlled-release generic and branded drugs.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.